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The invited Topical Reviews, symposia
articles and selected research papers in
this Special Issue of The Journal of
Physiology focus on the effects of ageing
on cardiovascular and skeletal muscle
function, including cardiac and muscle
performance in exercise. The articles
provide an up-to-date overview of the
molecular mechanisms underlying cardio-
vascular and skeletal muscle ageing and
further highlight the therapeutic potential
of targeting function to enhance healthspan
and longevity.
A recent Lancet series focused on
ageing (reviewed by Suzman et al.
2015) highlighted that ageing populations
constitute a global public health challenge,
noting that adults above 65 years of
age outnumber children under the age
of 5. Although rates of mortality and
morbidity have decreased due to medical
and socioeconomic developments, further
research is needed to enhance healthspan
(maintenance of good health) of older
adults by sustaining physiological function
and quality of life (Suzman et al. 2015).
As reviewed by Seals and colleagues in
this Special Issue, the term healthspan
is used to distinguish ‘healthy ageing’
from ‘age-related diseases and disability’
(Seals et al. 2016). Notably, increases
in longevity have predominantly been
attributed to individuals surviving longer
with an underlying disease(s) rather than an
increase in healthspan. Geriatric medicine
is facing an ever increasing burden from
ageing populations, and a key objective of
geroscience (biological ageing research) is
to identify strategies to enhance healthspan
(Seals et al. 2016). Thus, health care
systems need to focus on the wellbeing
of older adults living in both low- and
middle-income countries (Suzman et al.
2015).
As physiological function declines with
ageing, the efficacy of different interventions
to increase healthspan and/or longevity may
in some cases be limited. Russell Hepple and
Charles Rice review the evidence that ageing
is associated with motor neuron loss, neuro-
muscular junction instability and cycles of
denervation and reinnervation, resulting
ultimately in physical frailty (Hepple & Rice,
2016). These authors further conclude that,
although physical activity may promote
motor unit survival, exercise may not
necessarily benefit motor unit function in
advanced ageing. It is well known that
loss of skeletal muscle mass and function
in ageing contributes to frailty, yet the
underlying mechanisms remain to be fully
elucidated. Malcolm Jackson and Anne
McArdle provide novel molecular insights
into the role that reactive oxygen species play
in modulating skeletal muscle function and
how deficits in redox signalling contribute
to neuromuscular decline in ageing
(Jackson & McArdle, 2016), suggesting that
excessive mitochondrial hydrogen peroxide
generation may lead to partial or full
fibre denervation in older individuals.
The effects of exercise (intensity, duration,
frequency, type of exercise) on lifespan
remain to be defined more clearly in both
rodent models and humans, noting that
significant species differences have been
reported (Garcia-Valles et al. 2013). In their
Topical Review, Viña and colleagues propose
that exercise may serve as a ‘physiological’
stimulus not only for ameliorating disease
but also for improving healthy ageing and
thereby delaying the onset of frailty (Vina
et al. 2016).
In the 1950s, Denham Harman proposed
the ‘free radical theory of ageing’, which
states that ‘aging and the degenerative
diseases associated with it are attributed
basically to the deleterious side attacks
of free radicals on cell constituents and
on the connected tissues’ (Harman, 1956).
The ‘free radical theory of ageing’ has
recently been challenged, since it cannot
fully explain the ageing process (Vina
et al. 2013). Notably, reactive oxygen
species not only cause cellular damage but
also serve as ‘physiological’ modulators of
endogenous redox-sensitive transcription
factors regulating gene expression (Kunsch
& Medford, 1999; Siow & Mann, 2010; Ray
et al. 2012; Vina et al. 2013).
Enrique Cadenas and colleagues highlight
the importance of mitochondria in
redox homeostasis, emphasizing that
mitochondrial dysfunction may serve as
an ‘initiator’ of ageing-related disorders
in metabolically active tissues such as
brain, heart and liver (Yin et al.
2016). The schematic diagram in Fig. 4
of their Topical Review provides an
informed overview of the mechanisms by
which mitochondrial hydrogen peroxide
can modulate redox-sensitive transcription
factors involved in the regulation of cellular
antioxidant and inflammatory responses
(Yin et al. 2016). Cells have evolved end-
ogenous mechanisms to modulate basal
redox signalling and to counteract oxidative
stress, with the ubiquitous NF-E2-related
factor 2 (Nrf2)/kelch-like ECH associated
protein 1 (Keap1) defence pathway playing
a key role in the induction of antioxidant
enzymes (Ishii et al. 2004; Mann & Forman,
2015; Suzuki & Yamamoto, 2015; Tebay
et al. 2015). In this context, activation
of Nrf2 affects mitochondrial biogenesis
by counteracting increased generation
of mitochondrial reactive oxygen species
(Dinkova-Kostova & Abramov, 2015). As
highlighted by Guillero López-Lluch and
Plácido Navas, calorie restriction appears to
promote longevity in part by modulating
mitochondrial activity and cellular anti-
oxidant defences (Lopez-Lluch & Navas,
2016).
Francesco Cosentino and colleagues
highlight that only recent molecular
studies have identified common signalling
pathways linking the ageing process with
cardiovascular and metabolic diseases
(Costantino et al. 2016). Accumulation of
reactive oxygen species and mitochondrial
damage contribute to the development
of cardio-metabolic disorders such as
obesity and type 2 diabetes. These
authors further suggest that premature
dysregulation of genes involved in anti-
oxidant defences, insulin signalling,
autophagy and inflammation underlies
pathologies in the heart and vasculature.
Leah Cannon and Rolf Bodmer provide
valuable insights into the mechanisms
regulating genes associated with cardiac
ageing in Drosophila melanogaster (Cannon
& Bodmer, 2016), highlighting similarities
in genes linked with oxidative stress,
cardiac hypertrophy and neurodegenerative
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diseases in mammals and fruit flies. The
Topical Review by Timon Seeger and
Reinier Boon provides novel insights into
the mechanisms by which microRNAs
influence cardiovascular ageing, and in
particular that inhibition of miR-34a in
the myocardium may ameliorate cardiac
dysfunction and cardiomyocyte apoptosis
induced by ageing (Seeger & Boon, 2016).
In the context of age-related athero-
sclerosis, Giuseppe Poli and colleagues
review the molecular mechanisms by
which oxysterols and cholesterol oxidation
products accumulate in the vascular
wall (see Fig. 1 in their Topical Review),
promoting inflammation, oxidative stress
and apoptosis (Gargiulo et al. 2016).
Evidence for ‘accelerated biological ageing’
in atherosclerosis, reviewed by Anna
Uryga and Martin Bennett, indicates
that markers of ageing in atherosclerotic
plaques exceed those expected due to
chronological ageing (Uryga & Bennett,
2016). Leocadio Rodrı́guez-Mañas and
colleagues further review the importance
of long-term inflammation as a major
cause of vascular dysfunction and the
development of diabetes (El Assar et al.
2016). Notably, the majority of published
data have been obtained in animal models,
with only limited information available
for older patients with diabetes. In
addition to highlighting the importance
of NFκB in altered redox signalling in
diabetes and ageing-induced vascular
inflammation, these authors discuss
the evidence that diabetes significantly
impairs Nrf2-regulated gene transcription,
rendering cells and tissues more susceptible
to oxidative damage (Cheng et al. 2011,
2013; Uruno et al. 2013).
A Journal of Physiology research
symposium entitled ‘Vascular plasticity and
developmental conditioning: impact on
human health and ageing’ was coordinated
by Geraldine Clough (University of
Southampton) and Giovanni Mann
(King’s College London) at the 10th
World Conference for Microcirculation
held in Kyoto, Japan in September 2015.
The focus of this symposium was the
wider implications of a ‘developmental’
perspective on human ageing. Mark Hanson
and colleagues review the evidence that
epigenetic influences during development
may affect musculoskeletal and cardio-
vascular function in later life (Hanson
et al. 2016). Thus, adaptive responses
and susceptibility to disease in offspring
may be initiated in utero and/or early life
(Barker, 2002; Barker et al. 2006; Rodford
et al. 2008; Gluckman et al. 2009; Pinney
& Simmons, 2010; Bonacasa et al. 2011;
Torrens et al. 2012; Ozanne, 2014; Chapple
et al. 2015; Penfold & Ozanne, 2015;
Morton et al. 2016). Phoebe Stapleton
discusses the evidence that exposure of the
fetus to air pollution particulate matter
or nanomaterials not only affects the
mother and developing fetus but also may
predispose to disease susceptibility in later
life (Stapleton, 2016). Wong and colleagues
review the use of retinal vascular imaging
as a useful clinical application to examine
early life risk factors, e.g. in children
from pregnancies affected by intra-uterine
growth restriction (Li et al. 2016).
This Special Issue also contains review
articles from two research symposia
sponsored by The Physiological Society.
A symposium entitled ‘Impact of physical
activity, ageing, obesity and metabolic
syndrome on muscle microvascular
perfusion and endothelial metabolism’ was
held in London in 2014 and co-sponsored
by the European College of Sport Science.
The symposium editorial (Wagenmakers,
2016) provides a valuable overview of the
four review articles (Cocks & Wagenmakers,
2016; Frisbee et al. 2016; Keske et al. 2016;
Wagenmakers et al. 2016). The other
research symposium, entitled ‘Limitations
of skeletal muscle oxygen supply in ageing’,
was held in Edinburgh in 2015 and focused
on vascular adaptations during ageing
and skeletal muscle activity (Hearon &
Dinenno, 2016; Nyberg & Hellsten, 2016;
Thijssen et al. 2016).
The key objective of this Special Issue is
to provide researchers with an up-to-date
insight into the molecular mechanisms
underlying ageing-related changes in
cardiovascular and skeletal function. The
Topical and Symposium review articles and
associated primary papers (Boerman &
Segal, 2016) will be of interest to established
researchers as well as postdoctoral and
graduate students working in the fields
of ageing and cardiovascular and skeletal
muscle physiology.
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